Outline Intraductal proliferative lesions

Slides:



Advertisements
Similar presentations
Endometrial polyps Dr Shaun Monagle MBBS 1991.
Advertisements

Neoplasia II: Tumor Characteristics
Le lesioni colonnari Anna Sapino Università di Torino.
Atypical ductal hyperplasia “A diagnosis of ADH should not be made unless a diagnosis of low grade DCIS is being seriously considered” WHO Breast 2012.
ERCK5/6 Flat epithelial atypia Columnar cell lesions:  A spectrum: columnar cell change, columnar cell hyperplasia, flat epithelial atypia FEA has.
An audit of Endometrial Pathology cases referred to NGOC Dr Paul Cross Consultant Cellular Pathologist Queen Elizabeth Hospital Gateshead.
MICROCALCIFICATION IN BENIGN BREAST DISEASE
Benign Breast Disease – Focus on Atypia Lynn C. Hartmann, MD Women’s Cancer Program Mayo Clinic Cancer Center.
Histopathology and staging of breast cancer
Pathology Journal Reading
Breast Pathology Dr. M. Griffin.
Breast.
Breast Imaging Made Brief and Simple
Ductal Carcinoma In-Situ (DCIS)
Proliferative Epithelial lesions of the Breast
Dr. Malcolm Hayes BC Cancer Agency Vancouver, Canada
Menopause: The Journal of The North American Menopause Society
بسم الله الرحمن الرحيم. Interpretation of urine cytology Nashwa Emara M.D.,phd ASS. Prof. Pathology.
Breast Pathology. Breast pathology Inflammatory Disorders Acute Mastitis Preiductal Mastitis Mammary Duct Ectasia Fat Necrosis Lymphocytic Mastopathy.
FNA of breast Slide session The 6th Arab-British School of Pathology
Tutorial on Breast Pathology Part I: Ductal and Lobular Neoplasias Thomas J Lawton MD, Director Seattle Breast Pathology Consultants, LLC Seattle, WA.
QA CONFERENCE Conf #1, May 23, 2012 By Dr. E. Ravinsky.
Jump to first page First pregnancy after age 30 (RR 1.48). BMI >29 (RR 1.48). Being a college graduate, independent of OB-GYN history (RR 1.36). (Collaborative.
Atoosa Adibi MD. Department of Radiology Isfahan University Of Medical Sciences.
Session 5. Case Diagnosis - Sclerosing adenosis with lobular neoplasia. No invasion in images provided.
Pathology of The Breast- 1
Imaging examinations of breasts
Ductal Carcinoma In Situ Shahla Masood, M.D. Professor of Pathology University of Florida College of Medicine - Jacksonville Chief of Pathology and Laboratory.
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
Breast Pathology Emad Raddaoui, MD, FCAP, FASC
بسم الله الرحمن الرحیم. A 74 Y/O female with large right breast mass measured 5.5 x 4.5 x 4 cm.
DL Wickerham MD Deputy Chairman NRG Oncology Oct 5, 2015
Breast. Differential diagnosis for breast lump Malignant lump Breast abscess Fibrocystic changes: Lumpiness, thickening and swelling, often associated.
Neoplasia 1. a) Definition b) Terminologies Neoplasia “new growth” Definition: “an abnormal growth of tissue, the growth of which exceed and is uncoordinated.
Lesioni a cellule colonnari CON atipie (FEA/DIN1A) Lesioni a rischio evolutivo? Escissione sempre? SI ?
British/ Arab School of Pathology, June 2008 Slide Seminars.
Practical point There are some situations where atypia is noted, but other factors preclude a diagnosis of FEA, ADH, or DCIS. E.g. Very few cells,
W. Scott Campbell, Ph.D., MBA University of Nebraska Medical Center
Female Reproductive System Kristine Krafts, M.D..
Jacob J. Adler.  The following slides are meant for students to navigate on their own or in small groups.  They are expected to have time to research.
Jacob J. Adler.  The following slides are meant to supplement the background text in the manuscript. It is not meant to be presented alone.  The large.
Columnar Cell Lesions Timothy W. Jacobs, M.D. Department of Pathology Virginia Mason Medical Center Seattle, WA.
OVERVIEW OF BREAST PATHOLOGY Shahin Sayed, MMed, FCPath(ECSA) Assistant Professor, Department of Pathology, Aga Khan University Hospital, Nairobi.
Multistep model of breast cancer progression
Dr. Amit Gupta Associate Professor Dept Of Surgery
CHARACTERISTICS OF BENIGN AND MALIGNANT TUMORS
Ductal Carcinoma In situ of the Male Breast
Ductal carcinoma in situ (DCIS)
Patterns of ductal carcinoma in situ (DCIS)
W. Scott Campbell, MBA, PhD University of Nebraska Medical Center
Columnar cell lesions and atypical ductal hyperplasia
W. Scott Campbell, MBA, PhD University of Nebraska Medical Center
Ductal carcinoma in situ (DCIS)
FAMILIAL ADENOMATOUS POLYPOSIS
Dr. Sura Obay Al-Dewachi
Diseases of the breast (1 of 2)
The most common origin of cervical squamous cell carcinoma
Reporting precursors to invasive pancreatic cancer: pancreatic intraepithelial neoplasia, intraductal neoplasms and mucinous cystic neoplasm  Roeland.
Reporting precursors to invasive pancreatic cancer: pancreatic intraepithelial neoplasia, intraductal neoplasms and mucinous cystic neoplasm  Roeland.
Low grade intraductal proliferations: ADH vs DCIS
Rodolfo Montironi, Ming Zhou, Cristina Magi-Galluzzi, Jonathan I
Volume 62, Issue 3, Pages (September 2012)
Bottom Line Diagnostic reproducibility in the range of intraductal proliferative lesions is poor Even amongst breast pathology experts Even when specific.
Histological features that characterise Spitzoid lesions.
Mammary stem cells and progenitors: targeting the roots of breast cancer for prevention (A) Schematic of the human breast highlighting terminal ductal.
Gene promoter methylation analysis in ductal lavage fluid from cancer-free women at high risk for breast cancer and in women undergoing mastectomy for.
Low grade cervical glandular intraepithelial neoplasia in which there is mild nuclear atypia and easily identifiable mitotic figures and apoptotic bodies.
Presentation transcript:

Outline Intraductal proliferative lesions Usual ductal hyperplasia (UDH) Atypical ductal hyperplasia (ADH) Low grade DCIS Flat epithelial atypia (FEA) Clinical significance and management recommendations Not discussing: lobular neoplasia, intermediate and high grade lesions. Not much is helping us in this regard except we are seeing more of it due to increased resolution on mammos for calcs.

Intraductal proliferative lesions A group of cytologically and architecturally diverse proliferations originating in the TDLU. Increased risk for subsequent breast ca – but of vastly different magnitudes. ‘risk indicators’ VS ‘precursors’ Different genetics Different morphology: architecture, cytology, extent. This is about all they have in common.

UDH ADH DCIS INV CA CCL/FEA DIN terminology? UDH ADH HG DCIS LG DCIS Studies: IHC, gene-expression assays, CGH assays, LOH studies UDH shares few similarities with AHD, DCIS, CA (it has few and random chromosomal alterations) ADH shares many similarities with LG DCIS and CCL/FEA (the hallmark genetic alteration of low grade lesions is losses of chromosome 16q) LG DCIS and HG DCIS are genetically distinct FEA is a clonal lesion that is genetically similar to ADH, LG DCIS Thus, do FEA, ADH, and DCIS represent forms of intraepithelial neoplasia? LG DCIS INV CA

Genetics of intraductal proliferative lesions H CA Loss 16q FEA/CCL UDH ADH HG DCIS Studies: IHC, gene-expression assays, CGH assays, LOH studies UDH shares few similarities with AHD, DCIS, CA (it has few and random chromosomal alterations). Most represent ‘dead-end’ proliferations. ADH shares many similarities with LG DCIS and CCL/FEA (the hallmark genetic alteration of low grade lesions is losses of chromosome 16q) LG DCIS and HG DCIS are genetically distinct. DCIS and invasive carcinoma of similar grades share more genetic features than inv ca as a group. FEA is a clonal lesion that is genetically similar to ADH, LG DCIS. CCL (non atypical also show the same genetic changes but studies are limited. Most frequent is loss of 16q). Thus, do FEA, ADH, and DCIS represent forms of intraepithelial neoplasia? LG DCIS INV CA

Usual ductal hyperplasia Also known as epithelial hyperplasia of usual type Mild, moderate, florid – of no clinical significance* Architecture: solid, fenestrated, micropapillary (tapered), peripheral slit-like lumens, attenuated bridges Cytology: variable size and shape, overlapping, ill-defined cell borders, streaming of cells, necrosis is allowed. Occasional mitoses allowed. Compare to normal ducts for reference. *Some say that florid UDH has higher risk of breast ca.

CE 3887 UDH in complex sclerosing lesion.

36229 complex sclerosing lesion